SKLB-03220
Product Specifications
CAS Number
2852050-29-2
Target
Histone Methyltransferase
Related Pathways
Chromatin/Epigenetic
Purity
0.9702
Bioactivity
SKLB-03220 is an orally bioavailable covalent inhibitor targeting the histone methyltransferase EZH2, an established oncology drug target involved in epigenetic regulation. SKLB-03220 is structurally based on the clinically approved EZH2 inhibitor tazemetostat and demonstrates the ability to abolish epigenetic H3K27me3 marks, thereby altering chromatin state and transcriptional activity. SKLB-03220 represents a potent small-molecule tool for cancer epigenetics research.
Smiles
O=C(C=C)NC1=CC=C(C(=C1)C=2C=C(C(=O)NCC=3C(=O)NC(=CC3C)C)C(=C(C2)N(CC)C4CCOCC4)C)C
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
KF01-XL 1x 1 mg
KIF3C kinesin motor domain protein - GST tagged - Homo sapiens recombinant
Ask
View Details 
042916-ML650 100 µL
TMCC3, ID (TMCC3, KIAA1145, Transmembrane and coiled-coil domains protein 3) (MaxLight 650) discontinued
Ask
View Details 
MBS6182778-01 0.1 mL
IL17B (Interleukin 17B, IL-17B, IL-20, MGC138900, MGC138901, ZCYTO7) (HRP)
Ask
View Details 
MBS6182778-02 5x 0.1 mL
IL17B (Interleukin 17B, IL-17B, IL-20, MGC138900, MGC138901, ZCYTO7) (HRP)
Ask
View Details